Paragon Advanced Labs, Inc.

As of June 30, 2026, Paragon Advanced Labs, Inc. carries a market capitalization of 72.02M, placing it among publicly traded companies globally. Its enterprise value stands at 109.86M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Paragon Advanced Labs, Inc.'s next confirmed earnings release is scheduled for December 2, 2026.

As of June 30, 2026, Paragon Advanced Labs, Inc. has 32.74M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Paragon Advanced Labs, Inc. maintains a current ratio of 0.26, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,485.62, indicating conservative leverage, while an interest coverage ratio of -2.02 demonstrates limited ability to service its debt obligations.

These figures are as of the close on October 22, 2026. The 50-day moving average sits at 2.95, while the 200-day moving average is 3.06.

These figures cover the twelve months ended June 30, 2026.

As of June 30, 2026, Paragon Advanced Labs, Inc. holds 2.42M in cash and equivalents against 40.25M in total debt, resulting in a net debt position of 4.95M. Total book value stands at -2.71M, with working capital of -12.87M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026. After subtracting -972,050.00 in capital expenditures, free cash flow totaled -2.32M - equivalent to -0.07 per share.

Over the twelve months ended June 30, 2026, Paragon Advanced Labs, Inc. posted a gross margin of 10.26, reflecting its pricing power and cost economics. The operating margin of -67.25 and net profit margin of -82.01 provide insight into operational efficiency.